Ilmn stock price forecast investment banks updating ilmn stock

Investment banks updating ilmn stock price forecast advise cautious optimism. The biotech capital markets show resilience, and Illumina’s healthy balance sheet with over $1.5B in cash reserves provides flexibility for R&D scaling in 2024– According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025. It is expected to grow at a compound annual growth rate (CAGR) of 5.48% between 2025 and 2030, reaching $115.94 billion at the end of the forecast period. While North America is the largest market in the domain at present, Asia-Pacific takes the lead as the fastest growing. Be the first to know the most important updates across all our datasets -> Macro headwinds like inflation and interest rates factor into the ilmn stock price forecast, but sector-specific catalysts — such as reduced supply chain bottlenecks — could counterbalance downside risks.